Tolerability of N-chlorotaurine in the guinea pig middle ear: A pilot study using an improved application system

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 1, 2004, Pages 76-81

  Neher, Andreas ^a   Nagl, Markus ^b   Prieskorn, Diane ^c   Mitchell, Alice ^c   Brown, Nadine ^c   Schrott Fischer, Anneliese ^a   Miller, Josef M ^c,d  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Application system; Guinea pig; Middle ear; N chlorotaurine; Tolerability

Indexed keywords

N CHLOROTAURINE; NEOMYCIN; PHOSPHATE; SODIUM CHLORIDE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; BRAIN STEM RESPONSE; CANNULA; COCHLEA; COCHLEA FENESTRA; CONTROLLED STUDY; DIZZINESS; DRUG DELIVERY SYSTEM; EARDRUM; HAIR CELL; MIDDLE EAR; NONHUMAN; NYSTAGMUS; PILOT STUDY; PRIORITY JOURNAL;

EID: 0345827534     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300117     Document Type: Article

References (26)

1. Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician 2001;63:927-36, 941-2.
2. Kristiansen P. The diagnosis and management of malignant (necrotizing) otitis externa. J Am Acad Nurse Pract 1999;11: 297-300.
3. Nagl M, Gottardi W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 1996;21:597-605.
4. Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 2000;44:2507-13.
5. Nagl M, Lass-Floerl C, Neher A, Gunkel AR, Gottardi W. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 2001;47:871-4.
6. Weiss SJ, Lampert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983;222:625-8.
7. Marcinkiewicz J. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 1997; 18:577-80.
8. Gottardi W, Nagl M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm (Weinheim) 2002;335:411-21.
9. Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl Bakteriol 1998;288:217-23.
10. Nagl M, Teuchner B, Pöttinger E, Ulmer H, Gottardi W. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 2000;214:111-4.
11. Neher A, Nagl M, Schrott-Fischer A, et al. N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg 2001;127: 530-3.
12. Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813-23.
13. Juhn SK, Hamaguchi Y, Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol Suppl (Stockh) 1989(suppl 457):43-8.
14. Harada T, Iwamori M, Nagai Y, Nomura Y. Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol 1986;95: 404-8.
15. Okuno T, Nomura Y. Permeability of the round window membrane. Arch Otorhinolaryngol 1984;240:103-6.
16. Smith BM, Myers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979;87:888-91.
17. Bagger-Sjoback D, Lundman L, Nilsson-Ehle I. Ciprofloxacin and the inner ear - a morphological and round window membrane permeability study. ORL J Otorhinolaryngol Relat Spec 1992;54:5-9.
18. Ito Z, Kusakari J, Salt AN. Solute movement across the round window membrane in comparison with that across the blood-labyrinth barrier [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 1992;95:1959-67.
19. Engel F, Blatz R, Schliebs R, Palmer M, Bhakdi S. Bacterial cytolysin perturbs round window membrane permeability barrier in vivo: possible cause of sensorineural hearing loss in acute otitis media. Infect Immun 1998;66:343-6.
20. Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol (Stockh) 2001;121:437-47.
21. Perin G, Molinari GA. Biochemical study of the permeability of the round window membrane to NaCl and KCl [in Italian]. Boll Soc Ital Biol Sper 1969;45:576-8.
22. Mertens J. Effect of variations in middle ear pressure on ruptures of the round window membrane of the inner ear of the guinea pig (Cavia porcellus) [in German]. HNO 1995;43:611-8.
23. Kellner J, Studen A. Pressure measurements of the round window membrane in the guinea pig cochlea [in German]. Laryngol Rhinol Otol (Stuttg) 1987;66:133-5.
24. Prieskorn DM, Miller JM, Kaufmann J, et al. Subacute ototoxicity study with locally applied ciprofloxacin in the guinea pig. Abstract 122, Midwinter Meeting of the Association for Research in Otolaryngology, St Petersburg Beach, Fla, 1997.
25. Kringlebotn M. Rupture pressures of membranes in the ear. Ann Otol Rhinol Laryngol 2000;109:940-4.
26. Miriszlai E, Sandor P. Investigations on the critical perilymphatic pressure value causing round window membrane rupture in anesthetized cats. Acta Otolaryngol (Stockh) 1980;89: 323-9.